Additionally, this pathway has been linked to conditions like asthma, where persistent inflammation may involve sustained activation of IL-6 and STAT3, leading to chronic respiratory symptoms.[11] Understanding the role of the IL-6/STAT3 pathway across these different respiratory infections provides further insight into its potential as a therapeutic target in pediatric respiratory diseases. This evidence concerns the gene STAT3 and respiratory tract infectious disorder.